Cargando...
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Clinical development of bromodomain and extra‐terminal (BET) protein inhibitors differs from the traditional course of drug development. These drugs are simultaneously being evaluated for treating a wide spectrum of human diseases due to their novel mechanism of action. BET proteins are epigenetic “...
Gardado en:
| Publicado en: | Med Res Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756446/ https://ncbi.nlm.nih.gov/pubmed/32926459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/med.21730 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|